NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 639518 | Cyclopentanone, 2-[[4-(benzoyloxy)-3-methoxyphenyl] methylene]-5-[(dimethylamino)methyl]-, hydrochloride | 0.0202245331784477 | 0.6850482 |
NSC 641319 | 5,12-Naphthacenedione, 10-[[3-[[5,5-di(acetyloxy)pentyl]amino]- 2,3,6-trideoxy-.alpha.-L-lyxohexopyranosyl]oxy]- 7,8,9,10-tetrahydro-6,8,11-trihydroxy- 8-(hydroxyacetyl)-1-methoxy-, hydrochloride | 0.0202245331784477 | 0.5772543 |
NSC 642282 | Null | 0.0202245331784477 | 0.056175966 |
NSC 642306 | Null | 0.0202245331784477 | -0.10432485 |
NSC 645210 | 1,4-Naphthalenedione, 2-chloro-3-[[2-(2-fluorophenyl)- 1-oxoethyl]amino]- | 0.0202245331784477 | 0.51991243 |
NSC 647395 | Null | 0.0202245331784477 | 0.75616419 |
NSC 655901 | ANTINEOPLASTIC-655901 | 0.0202245331784477 | 0.19950768 |
NSC 65628 | Null | 0.0202245331784477 | 0.49093591 |
NSC 666850 | Null | 0.0202245331784477 | 0.54638804 |
NSC 670226 | trans-2((1-(4-fluorphenyl-methyl)-4-tert.butylcyclohexyl)oxy)N,N-dimethyl-1-ethanamine-, salt with fumaric acid | 0.0202245331784477 | 0.2851331 |